14 results
ARS
2024 FY
CCCC
C4 Therapeutics Inc
30 Apr 24
Annual report to shareholders
8:52am
in the event of a security incident. These types of mandatory disclosures are costly, could lead to negative publicity, and may cause our partners to lose
ARS
sf9du1ww4d5
28 Apr 23
Annual report to shareholders
7:03am
S-3ASR
EX-1.2
cq4v28vk1gpz0yars
10 Nov 21
Automatic shelf registration
5:19pm
S-1
EX-10.14
z3fmfaldae13f2
10 Sep 20
IPO registration
5:26pm
S-1
EX-3.4
noz03btm
10 Sep 20
IPO registration
5:26pm
DRS
EX-10.9
dwo40k eftdz54n8
6 Aug 20
Draft registration statement
12:00am
DRS
EX-3.3
6j1c wnx4gp
6 Aug 20
Draft registration statement
12:00am
- Prev
- 1
- Next